Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Bertin Bioreagent
anti-Bromocriptine and its main metabolites, pAb
As low as
579
CHF
CHF 579.00
In stock
Only %1 left
BRT-A03612-T500500 dtnCHF 579.00
NEW
| Product Details | |
|---|---|
| Product Type | Polyclonal Antibody |
| Properties | |
| Source/Host | Rabbit |
| Immunogen/Antigen | Bromolysergic acid-BSA. |
| Application | EIA |
| Formulation | Liquid. In Phosphate Buffer. |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| Declaration | Manufactured by Bertin Bioreagent |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Long Term Storage | +4°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
| Documents | |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
Bromocriptine is a dopamine D2 receptor agonist. It also binds to the serotonin (5-HT) receptor subtypes 5-HT1A and 5-HT1D, as well as α1-adrenergic receptors. Formulations containing bromocriptine have been used in the treatment of Parkinson's disease, hyperprolactinemia-associated dysfunctions and acromegaly. Bromocriptine undergoes hepatic metabolism and is primarily processed in the liver. The main metabolites of bromocriptine are Bromocriptine N-oxide and Hydroxybromocriptine. These metabolites are excreted mainly in the urine.